Rapid Microbiology Testing Market by Product (Reagents, Kits, Automated Identification System, PCR, Mass Spectrometry), Method (Growth, Nucleic Acid, Viability), Applications (Clinical Diagnosis, Pharma, Environmental) - Global Forecast to 2026
[276 Pages Report] The global rapid microbiology testing market is projected to reach USD 6.7 billion by 2026 from USD 4.2 billion in 2021, at a CAGR of 9.4%. Market growth is driven by the increased focus on the early detection of infectious disease, technological advancements, increased funding for R&D and increasing incidence of infectious disease.
To know about the assumptions considered for the study, Request for Free Sample Report
COVID-19 Impact on Global Rapid Microbiology Testing Market
The emergence of the COVID-19 pandemic has changed the delivery of medical care across the world. The COVID-19 pandemic has significantly affected the rapid microbiology testing market. The market has faced challenges in the manufacturing and supply chain, such as delivering products to end users in a timely manner as well as attending to an uneven demand for the products and services in the sector. In addition, a dearth of skilled laboratory professionals to conduct/study diagnostic tests, limited operations in most of the industries, inadequate funding for research and academic institutes, and challenges in providing essential/post-sales services due to lockdowns have led to the reduced supply of rapid microbiology testing products to end users. Research institutes are one of the major end users of rapid microbiology testing products. As the pandemic resulted in the temporary closure of several institutes across the globe, this end-user segment has been affected drastically in the last few months.
Despite the challenging situation, industries are gradually recovering from the impact, and supply and distribution channels have also resumed. Also, significant research activities on SARS-CoV-2-related vaccines, diagnostic test kits, and drugs by major countries (such as the US, Russia, China, and India) have increased the demand for rapid microbiology testing.
Market Dynamics
Driver: Increasing incidence of infectious disease and cancer.
The incidence of various infectious diseases such as HIV, tuberculosis, malaria, and pneumonia has increased. With a rise in the global burden of these diseases, the demand for rapid microbiology techniques for faster and accurate microbial screening, identification, and susceptibility testing against pathogens is expected to witness significant growth during the forecast period
Opportunity: Growth opportunities in emerging countries
Emerging economies such as India, South Korea, Brazil, and Mexico offer significant growth opportunities to players operating in the rapid microbiology testing market. This can be attributed to the low regulatory barriers, improvements in healthcare infrastructure, growing patient population, rising prevalence of infectious diseases, and rising healthcare expenditure. Moreover, the regulatory policies in some of these countries are more adaptive and business-friendly than those in developed countries has drawn key players in the rapid microbiology testing market to focus on emerging countries.
Restraint: High capital investments and low cost-benefit ratio.
Significant capital investments are required for the discovery, development, and validation of efficient rapid tests. Additionally, due to the high drug attrition in clinical trials (with almost 30% of drugs failing in Phase III), diagnostic manufacturers are exposed to significant financial challenges. To gain approval for in vitro diagnostics (IVD) from regulators, manufacturers need successful Phase III clinical trials. Huge investments are required to run clinical trials and address stringent regulatory requirements, which not only affects the ability of small companies to develop tests but also severely affects innovation. Hence, along with the high amount of capital investments, the low cost-benefit ratio is hindering the growth of the rapid microbiology testing market.
Challenge: Operational barriers
Clinical laboratories across major markets are still evolving; technicians face operational challenges in ensuring effective sample procurement, storage, and transportation, especially while adopting novel technologies such as NGS and lab-on-a-chip PCR devices. Laboratory space also needs to be reconfigured to meet the requirements of conducting specific diagnostic tests used for pathogen detection as a means of avoiding cross-contamination and ensuring efficient time management. This results in considerable cost escalation to maintain and operate advanced rapid microbiology tests, particularly those capable of handling a single sample type. Furthermore, due to the rapid mutation of microbes and the increasing outbreak of epidemics, clinical laboratories need to adopt innovative technologies capable of rapid sample diagnosis.
“In 2020, instruments accounted for the largest share of the rapid microbiology testing market, by product”
The rapid microbiology testing market is segmented into instruments, reagents and kits and consumables based on product. The instrument segment accounted for the largest share of the rapid microbiology testing market in 2020, mainly due to the increased funding for R&D, increasing incidence of infectious disease and cancer and technological advancements.
“In 2020, growth-based rapid microbiology testing segment accounted for the largest share in the market, by method”
The rapid microbiology testing market is segmented into growth-based, cellular-based, nucleic acid-based, viability-based and other rapid microbiology testing based on method. In 2020, the growth-based rapid microbiology testing segment accounted for the largest share. Factors such as increased focus on the early detection of infectious disease increased funding for R&D and increased incidence of infectious disease and cancer.
“In 2020, clinical disease diagnosis segment accounted for the largest share in the market, by applications”
The rapid microbiology testing market has been segmented into clinical disease diagnosis, food and beverage testing, pharmaceutican and biological drug testing, environmental testing, cosmetics and personal care products testing , research applications and other applications based on applications. In 2020, the clinical disease diagnostics segment accounted for the largest share of the rapid microbiology testing market. The increasing incidence of infectious disease and cancer is driving the growth of this segment.
“North America is the largest regional market for rapid microbiology tests”
The global rapid microbiology testing market is segmented into five major regions—North America, Europe, the Asia Pacific, Latin America, and the Middle East & Africa. In 2020, North America accounted for the largest share of the global rapid microbiology testing market. The North American rapid microbiology testing market's growth can be attributed to the, increased funding for R&D, increased focus on the early detection of infectious disease and increased incidence of infectious disease and cancer.
To know about the assumptions considered for the study, download the pdf brochure
Some key players in the rapid microbiology testing market (2021- 2026)
- Biomérieux SA (France)
- Danaher Corporation (US)
- Becton, Dickinson and Company (US)
- Abbott Laboratories, Inc. (US)
- Thermo Fisher Scientific (US)
Get online access to the report on the World's First Market Intelligence Cloud
- Easy to Download Historical Data & Forecast Numbers
- Company Analysis Dashboard for high growth potential opportunities
- Research Analyst Access for customization & queries
- Competitor Analysis with Interactive dashboard
- Latest News, Updates & Trend analysis
Request Sample Scope of the Report
Get online access to the report on the World's First Market Intelligence Cloud
- Easy to Download Historical Data & Forecast Numbers
- Company Analysis Dashboard for high growth potential opportunities
- Research Analyst Access for customization & queries
- Competitor Analysis with Interactive dashboard
- Latest News, Updates & Trend analysis
|
Report Metric |
Details |
|
Market size available for years |
2016–2026 |
|
Base year considered |
2020 |
|
Forecast period |
2021–2026 |
|
Forecast units |
Value (USD Billion) |
|
Segments covered |
Product, method, applications, and region |
|
Geographies covered |
North America, Europe, Asia Pacific, Latin America, and the Middle East & Africa |
|
Companies covered |
Abbott Laboratories, Inc. (US), Becton, Dickinson and Company (US), bioMérieux SA (France), Bruker Corporation (US), Charles River Laboratories International, Inc. (US), Danaher Corporation (US), Merck KGaA (Germany), NEOGEN Corporation (US), Quidel Corporation (US), Sartorius AG (Germany), Thermo Fisher Scientific, Inc. (US), Don Whitley Scientific Limited (UK), Rapid Micro Biosystems, Inc. (US), Vivione Biosciences, LLC (US), Gradientech (Sweden), rqmicro AG (Switzerland), Bactest Ltd. (US), Colifast (Norway), Serosep Ltd. (Ireland), Biosensia (Ireland), Solus Scientific Solutions Ltd. (Scotland), LubioScience GmbH (Scotland), Euroclone SpA (Italy), CorDx (US), and R-Biopharm AG (Germany). |
This report categorizes the rapid microbiology testing market into the following segments and subsegments:
By Product
- Instruments
- Automated Microbial Identification & Antimicrobial Susceptibility Testing System
- Mass Spectrometers
- Bioluminescence & Fluorescence-Based Detection System
- PCR Systems
- Cytometers
- Active Air Samplers
- Other Instruments
- Reagents and Kits
- Sterility Reagents and Kits
- Other Reagents and Kits
- Consumables
By Method
- Growth-Based Rapid Microbiology Testing
- Cellular component-Based Rapid Microbiology Testing
- Nucleic Acid-Based Rapid Microbiology Testing
- Viability-Based Rapid Microbiology Testing
By Applications
- Clinical Disease Diagnostics
- Food & Beverage testing
- Pharmaceutical & Biological Drug Testing
- Environmental Testing
- Cosmetics and Personal Care Products Testing
- Research Applications
- Other Applications
By Region
- North America
- US
- Canada
- Europe
- Germany
- France
- UK
- Rest of Europe
- Asia Pacific
- China
- India
- Japan
- Rest of Asia Pacific
- Latin America
- Middle East & Africa
Recent Developments
- In October 2020, Merck KGAA (Germany) collaborated with Mammoth Biosciences (US) for the development, scale up and commercial production of CRISPR- based SARS-COV-2 diagnostic test.
- In September 2020, Bruker Corporation (US) has an acquisition with Canopy Bioscience LLC ( US) which enhanced bruker’s offerings in targeted multi-omics and fluorescence-based imaging technique.
- In July 2020, Biomérieux SA (France) launched Biofire mycoplasma test for the detection of mycoplasma in biopharmaceutical products.
Frequently Asked Questions (FAQ):
What are the recent trends affecting the rapid microbiology testing market?
Recent trends affecting the rapid microbiology testing market are the COVID-19 outbreak, rising incidence of infectious disease and cancer and increased focus on the early detection of infectious disease.
What are the major products of rapid microbiology tests?
The rapid microbiology test market is segmented into instruments, reagents and kits and consumables based on product. In 2020, the instrument segment accounted for the largest share. The increased funding on R&D, Technological advancements and increased focus on early detection of infectious disease are major drivers.
Who are the key players in the rapid microbiology testing market?
The key players in this market are: Abbott Laboratories, Inc. (US), Becton, Dickinson and Company (US), bioMérieux SA (France), Bruker Corporation (US), Charles River Laboratories International, Inc. (US), Danaher Corporation (US), Merck KGaA (Germany), NEOGEN Corporation (US), Quidel Corporation (US), Sartorius AG (Germany), Thermo Fisher Scientific, Inc. (US), Don Whitley Scientific Limited (UK), Rapid Micro Biosystems, Inc. (US), Vivione Biosciences, LLC (US), Gradientech (Sweden), rqmicro AG (Switzerland), Bactest Ltd. (US), Colifast (Norway), Serosep Ltd. (Ireland), Biosensia (Ireland), Solus Scientific Solutions Ltd. (Scotland), LubioScience GmbH (Scotland), Euroclone SpA (Italy), CorDx (US), and R-Biopharm AG (Germany).
Who are the major applications of rapid microbiology testing market?
Based on applications, the rapid microbiology testing market has been segmented into clinical disease diagnosis, food and beverage testing, pharmaceutican and biological drug testing, environmental testing, cosmetics and personal care products testing, research applications and other applications based on applications. In 2020, the clinical disease diagnostics segment accounted for the largest share of the rapid microbiology testing market. The increased funding on R&D, increasing incidence of infectious disease and cancer is driving the growth of this segment.
Which region is lucrative for the rapid microbiology testing market?
Like China, India and Japan, the emerging economies in the Asia Pacific region will be the lucrative markets for rapid microbiology testing. .
To speak to our analyst for a discussion on the above findings, click Speak to Analyst
TABLE OF CONTENTS
1 INTRODUCTION (Page No. - 36)
1.1 OBJECTIVES OF THE STUDY
1.2 MARKET DEFINITION
1.2.1 INCLUSIONS & EXCLUSIONS OF THE STUDY
1.2.2 MARKETS COVERED
FIGURE 1 RAPID MICROBIOLOGY TESTING MARKET SEGMENTATION
1.2.3 YEARS CONSIDERED FOR THE STUDY
1.3 CURRENCY
1.4 LIMITATIONS
1.5 STAKEHOLDERS
1.6 SUMMARY OF CHANGES
2 RESEARCH METHODOLOGY (Page No. - 42)
2.1 RESEARCH DATA
2.2 RESEARCH APPROACH
FIGURE 2 RAPID MICROBIOLOGY TESTING MARKET: RESEARCH DESIGN
2.2.1 SECONDARY DATA
2.2.1.1 Key data from secondary sources
2.2.2 PRIMARY DATA
2.2.2.1 Key data from primary sources
2.2.2.2 Key industry insights
FIGURE 3 BREAKDOWN OF PRIMARY INTERVIEWS: BY COMPANY TYPE, DESIGNATION, AND REGION
2.3 MARKET SIZE ESTIMATION
2.3.1 BOTTOM-UP APPROACH
FIGURE 4 RAPID MICROBIOLOGY TESTING MARKET: BOTTOM-UP APPROACH
FIGURE 5 CAGR PROJECTIONS: SUPPLY-SIDE ANALYSIS
2.3.2 TOP-DOWN APPROACH
FIGURE 6 RAPID MICROBIOLOGY TESTING MARKET: TOP-DOWN APPROACH
2.4 MARKET BREAKDOWN & DATA TRIANGULATION
FIGURE 7 DATA TRIANGULATION METHODOLOGY
2.5 ASSUMPTIONS FOR THE STUDY
2.6 GROWTH RATE ASSUMPTIONS
2.7 LIMITATIONS
2.8 RISK ASSESSMENT
2.9 COVID-19 HEALTH ASSESSMENT
2.10 COVID-19 ECONOMIC ASSESSMENT
2.11 ASSESSMENT OF THE IMPACT OF COVID-19 ON THE ECONOMIC SCENARIO
FIGURE 8 CRITERIA IMPACTING THE GLOBAL ECONOMY
FIGURE 9 RECOVERY SCENARIO OF THE GLOBAL ECONOMY
2.12 ASSESSMENT OF THE IMPACT OF COVID-19 ON THE RAPID MICROBIOLOGY TESTING MARKET
3 EXECUTIVE SUMMARY (Page No. - 56)
FIGURE 10 RAPID MICROBIOLOGY TESTING MARKET, BY PRODUCT, 2021 VS. 2026 (USD MILLION)
FIGURE 11 RAPID MICROBIOLOGY TESTING MARKET, BY METHOD, 2021 VS. 2026 (USD MILLION)
FIGURE 12 RAPID MICROBIOLOGY TESTING MARKET, BY APPLICATION, 2021 VS. 2026 (USD MILLION)
FIGURE 13 RAPID MICROBIOLOGY TESTING MARKET, BY REGION, 2021 VS. 2026 (USD MILLION)
4 PREMIUM INSIGHTS (Page No. - 60)
4.1 RAPID MICROBIOLOGY TESTING MARKET OVERVIEW
FIGURE 14 RISING INCIDENCE OF INFECTIOUS DISEASES TO DRIVE MARKET GROWTH
4.2 RAPID MICROBIOLOGY TESTING MARKET SHARE, BY PRODUCT, 2021 VS. 2026
FIGURE 15 INSTRUMENTS SEGMENT WILL CONTINUE TO DOMINATE THE MARKET IN 2026
4.3 RAPID MICROBIOLOGY TESTING MARKET SHARE, BY METHOD, 2021 VS. 2026
FIGURE 16 GROWTH-BASED RAPID MICROBIOLOGY TESTING SEGMENT TO DOMINATE THE MARKET DURING THE FORECAST PERIOD
4.4 RAPID MICROBIOLOGY TESTING MARKET SHARE, BY APPLICATION, 2021 VS. 2026
FIGURE 17 CLINICAL DISEASE DIAGNOSIS IS THE LARGEST APPLICATION SEGMENT OF RAPID MICROBIOLOGY TESTS
4.5 RAPID MICROBIOLOGY TESTING MARKET: GEOGRAPHIC GROWTH OPPORTUNITIES
FIGURE 18 ASIA PACIFIC TO REGISTER THE HIGHEST GROWTH RATE IN THE RAPID MICROBIOLOGY TESTING MARKET DURING THE FORECAST PERIOD
5 MARKET OVERVIEW (Page No. - 64)
5.1 INTRODUCTION
5.2 MARKET DYNAMICS
FIGURE 19 RAPID MICROBIOLOGY TESTING MARKET: DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES
5.2.1 DRIVERS
5.2.1.1 Increasing incidence of infectious diseases and cancer
5.2.1.2 Technological advancements in rapid microbiology testing
5.2.1.3 Increased funding for R&D
5.2.1.4 Increased focus on the early detection of infectious diseases
5.2.2 RESTRAINTS
5.2.2.1 High capital investments and low cost-benefit ratio
5.2.2.2 Unfavorable regulatory and reimbursement scenarios
5.2.3 OPPORTUNITIES
5.2.3.1 Growth opportunities in emerging countries
5.2.4 CHALLENGES
5.2.4.1 Operational barriers
5.3 IMPACT OF COVID-19 ON THE RAPID MICROBIOLOGY TESTING MARKET
5.3.1 GLOBAL TREND IN THE SARS-COV-2 RAPID DIAGNOSTICS MARKET
5.4 PRICING ANALYSIS
TABLE 1 PRICES OF RAPID MICROBIOLOGY TESTS (2021)
5.5 PATENT ANALYSIS
5.6 TRADE ANALYSIS
5.6.1 TRADE ANALYSIS FOR DIAGNOSTIC AND LABORATORY REAGENTS
TABLE 2 IMPORT DATA FOR DIAGNOSTIC AND LABORATORY REAGENTS, BY COUNTRY, 2016–2020 (USD MILLION)
TABLE 3 EXPORT DATA FOR DIAGNOSTIC AND LABORATORY REAGENTS, BY COUNTRY, 2016–2020 (USD MILLION)
5.7 VALUE CHAIN ANALYSIS
FIGURE 20 MAJOR VALUE IS ADDED DURING THE MANUFACTURING & ASSEMBLY PHASES
5.8 SUPPLY CHAIN ANALYSIS
FIGURE 21 DISTRIBUTION—A STRATEGY PREFERRED BY PROMINENT COMPANIES
5.9 ECOSYSTEM ANALYSIS OF THE RAPID MICROBIOLOGY TESTING MARKET
FIGURE 22 RAPID MICROBIOLOGY TESTING MARKET: ECOSYSTEM ANALYSIS
5.10 PORTER’S FIVE FORCES ANALYSIS
TABLE 4 RAPID MICROBIOLOGY TESTING MARKET: PORTER’S FIVE FORCES ANALYSIS
5.10.1 THREAT OF NEW ENTRANTS
5.10.2 THREAT OF SUBSTITUTES
5.10.3 BARGAINING POWER OF BUYERS
5.10.4 BARGAINING POWER OF SUPPLIERS
5.10.5 DEGREE OF COMPETITION
5.11 PESTLE ANALYSIS
5.12 REGULATORY LANDSCAPE
5.12.1 NORTH AMERICA
5.12.1.1 US
5.12.1.2 Canada
5.12.2 EUROPE
5.12.3 ASIA PACIFIC
5.12.3.1 Japan
5.12.3.2 India
5.12.3.3 China
5.12.4 LATIN AMERICA
5.12.4.1 Brazil
5.12.4.2 Mexico
5.12.5 MIDDLE EAST
5.12.6 AFRICA
5.13 TECHNOLOGY ANALYSIS
5.14 DISRUPTIVE TECHNOLOGIES IN THE RAPID MICROBIOLOGY TESTING MARKET
5.14.1 REVENUE SHIFT & REVENUE POCKETS FOR THE RAPID MICROBIOLOGY TESTING MARKET
FIGURE 23 REVENUE SHIFT FOR THE RAPID MICROBIOLOGY TESTING MARKET
6 RAPID MICROBIOLOGY TESTING MARKET, BY PRODUCT (Page No. - 81)
6.1 INTRODUCTION
TABLE 5 RAPID MICROBIOLOGY TESTING MARKET, BY PRODUCT, 2016–2019 (USD MILLION)
TABLE 6 RAPID MICROBIOLOGY TESTING MARKET, BY PRODUCT, 2020–2026 (USD MILLION)
6.2 INSTRUMENTS
TABLE 7 KEY PRODUCTS IN THE RAPID MICROBIOLOGY INSTRUMENTS MARKET
TABLE 8 RAPID MICROBIOLOGY TESTING INSTRUMENTS MARKET, BY TYPE, 2016–2019 (USD MILLION)
TABLE 9 RAPID MICROBIOLOGY TESTING INSTRUMENTS MARKET, BY TYPE, 2020–2026 (USD MILLION)
TABLE 10 RAPID MICROBIOLOGY TESTING INSTRUMENTS MARKET, BY REGION, 2016–2019 (USD MILLION)
TABLE 11 RAPID MICROBIOLOGY TESTING INSTRUMENTS MARKET, BY REGION, 2020–2026 (USD MILLION)
6.2.1 AUTOMATED MICROBIAL IDENTIFICATION & ANTIMICROBIAL SUSCEPTIBILITY TESTING SYSTEMS
6.2.1.1 Ease of use as compared to conventional identification processes is the major factor supporting the growth of this segment
TABLE 12 RAPID MICROBIOLOGY TESTING MARKET FOR AUTOMATED MICROBIAL IDENTIFICATION & ANTIMICROBIAL SUSCEPTIBILITY TESTING SYSTEMS, BY REGION, 2016–2019 (USD MILLION)
TABLE 13 RAPID MICROBIOLOGY TESTING MARKET FOR AUTOMATED MICROBIAL IDENTIFICATION & ANTIMICROBIAL SUSCEPTIBILITY TESTING SYSTEMS, BY REGION, 2020–2026 (USD MILLION)
6.2.2 MASS SPECTROMETERS
6.2.2.1 Mass spectrometry methods provide rapid results for microbial identification within a few minutes
TABLE 14 RAPID MICROBIOLOGY TESTING MARKET FOR MASS SPECTROMETERS, BY REGION, 2016–2019 (USD MILLION)
TABLE 15 RAPID MICROBIOLOGY TESTING MARKET FOR MASS SPECTROMETERS, BY REGION, 2020–2026 (USD MILLION)
6.2.3 BIOLUMINESCENCE & FLUORESCENCE-BASED DETECTION SYSTEMS
6.2.3.1 Unwanted detection of non-microbial ATP is one of the major disadvantages associated with this technique
TABLE 16 RAPID MICROBIOLOGY TESTING MARKET FOR BIOLUMINESCENCE & FLUORESCENCE-BASED DETECTION SYSTEMS, BY REGION, 2016–2019 (USD MILLION)
TABLE 17 RAPID MICROBIOLOGY TESTING MARKET FOR BIOLUMINESCENCE & FLUORESCENCE-BASED DETECTION SYSTEMS, BY REGION, 2020–2026 (USD MILLION)
6.2.4 PCR SYSTEMS
6.2.4.1 Standard PCR, real-time PCR, and qPCR are the common PCR techniques used for rapid microbial testing
TABLE 18 RAPID MICROBIOLOGY TESTING MARKET FOR PCR SYSTEMS, BY REGION, 2016–2019 (USD MILLION)
TABLE 19 RAPID MICROBIOLOGY TESTING MARKET FOR PCR SYSTEMS, BY REGION, 2020–2026 (USD MILLION)
6.2.5 CYTOMETERS
6.2.5.1 Ability to detect viable organisms to support market growth
TABLE 20 RAPID MICROBIOLOGY TESTING MARKET FOR CYTOMETERS, BY REGION, 2016–2019 (USD MILLION)
TABLE 21 RAPID MICROBIOLOGY TESTING MARKET FOR CYTOMETERS, BY REGION, 2020–2026 (USD MILLION)
6.2.6 ACTIVE AIR SAMPLERS
6.2.6.1 Rapid active air samplers are convenient and easy to use and offer more sensitive and complete results in real-time
TABLE 22 RAPID MICROBIOLOGY TESTING MARKET FOR ACTIVE AIR SAMPLERS, BY REGION, 2016–2019 (USD MILLION)
TABLE 23 RAPID MICROBIOLOGY TESTING MARKET FOR ACTIVE AIR SAMPLERS, BY REGION, 2020–2026 (USD MILLION)
6.2.7 OTHER INSTRUMENTS
TABLE 24 RAPID MICROBIOLOGY TESTING MARKET FOR OTHER INSTRUMENTS, BY REGION, 2016–2019 (USD MILLION)
TABLE 25 RAPID MICROBIOLOGY TESTING MARKET FOR OTHER INSTRUMENTS, BY REGION, 2020–2026 (USD MILLION)
6.3 REAGENTS & KITS
TABLE 26 RAPID MICROBIOLOGY TESTING REAGENTS & KITS MARKET, BY TYPE, 2016–2019 (USD MILLION)
TABLE 27 RAPID MICROBIOLOGY TESTING REAGENTS & KITS MARKET, BY TYPE, 2020–2026 (USD MILLION)
TABLE 28 RAPID MICROBIOLOGY TESTING REAGENTS & KITS MARKET, BY REGION, 2016–2019 (USD MILLION)
TABLE 29 RAPID MICROBIOLOGY TESTING REAGENTS & KITS MARKET, BY REGION, 2020–2026 (USD MILLION)
6.3.1 STERILITY REAGENTS & KITS
6.3.1.1 Increasing adoption of BET assays to propel market growth
TABLE 30 RAPID MICROBIOLOGY TESTING MARKET FOR STERILITY TESTING REAGENTS & KITS, BY REGION, 2016–2019 (USD MILLION)
TABLE 31 RAPID MICROBIOLOGY TESTING MARKET FOR STERILITY TESTING REAGENTS & KITS, BY REGION, 2020–2026 (USD MILLION)
6.3.2 OTHER REAGENTS & KITS
TABLE 32 RAPID MICROBIOLOGY TESTING MARKET FOR OTHER REAGENTS & KITS, BY REGION, 2016–2019 (USD MILLION)
TABLE 33 RAPID MICROBIOLOGY TESTING MARKET FOR OTHER REAGENTS & KITS, BY REGION, 2020–2026 (USD MILLION)
6.4 CONSUMABLES
6.4.1 DEVELOPMENT OF AUTOMATED ZONE READERS AND DISPENSERS TO DRIVE MARKET GROWTH
TABLE 34 RAPID MICROBIOLOGY TESTING CONSUMABLES MARKET, BY REGION, 2016–2019 (USD MILLION)
TABLE 35 RAPID MICROBIOLOGY TESTING CONSUMABLES MARKET, BY REGION, 2020–2026 (USD MILLION)
7 RAPID MICROBIOLOGY TESTING MARKET, BY METHOD (Page No. - 102)
7.1 INTRODUCTION
TABLE 36 RAPID MICROBIOLOGY TESTING MARKET, BY METHOD, 2016–2019 (USD MILLION)
TABLE 37 RAPID MICROBIOLOGY TESTING MARKET, BY METHOD, 2020–2026 (USD MILLION)
TABLE 38 TYPES OF TECHNOLOGIES USED IN VARIOUS RAPID MICROBIOLOGY TESTING METHODS
7.2 GROWTH-BASED RAPID MICROBIOLOGY TESTING
7.2.1 GROWTH-BASED RAPID MICROBIOLOGY TESTING IS THE LARGEST METHOD SEGMENT
TABLE 39 GROWTH-BASED RAPID MICROBIOLOGY TESTING MARKET, BY REGION, 2016–2019 (USD MILLION)
TABLE 40 GROWTH-BASED RAPID MICROBIOLOGY TESTING MARKET, BY REGION, 2020–2026 (USD MILLION)
7.3 CELLULAR COMPONENT-BASED RAPID MICROBIOLOGY TESTING
7.3.1 THIS METHOD OFFERS A HIGH LEVEL OF SENSITIVITY, ACCURACY, AND SPECIFICITY
TABLE 41 CELLULAR COMPONENT-BASED RAPID MICROBIOLOGY TESTING MARKET, BY REGION, 2016–2019 (USD MILLION)
TABLE 42 CELLULAR COMPONENT-BASED RAPID MICROBIOLOGY TESTING MARKET, BY REGION, 2020–2026 (USD MILLION)
7.4 NUCLEIC ACID-BASED RAPID MICROBIOLOGY TESTING
7.4.1 NUCLEIC ACID-BASED METHODS TO REGISTER THE HIGHEST GROWTH IN THE FORECAST PERIOD
TABLE 43 NUCLEIC ACID-BASED RAPID MICROBIOLOGY TESTING MARKET, BY REGION, 2016–2019 (USD MILLION)
TABLE 44 NUCLEIC ACID-BASED RAPID MICROBIOLOGY TESTING MARKET, BY REGION, 2020–2026 (USD MILLION)
7.5 VIABILITY-BASED RAPID MICROBIOLOGY TESTING
7.5.1 NEAR REAL-TIME DETECTION AND IMPROVED ACCURACY ARE SOME OF THE ADVANTAGES DRIVING THE ADOPTION OF THIS SEGMENT
TABLE 45 VIABILITY-BASED RAPID MICROBIOLOGY TESTING MARKET, BY REGION, 2016–2019 (USD MILLION)
TABLE 46 VIABILITY-BASED RAPID MICROBIOLOGY TESTING MARKET, BY REGION, 2020–2026 (USD MILLION)
7.6 OTHER RAPID MICROBIOLOGY TESTING METHODS
TABLE 47 OTHER RAPID MICROBIOLOGY TESTING METHODS MARKET, BY REGION, 2016–2019 (USD MILLION)
TABLE 48 OTHER RAPID MICROBIOLOGY TESTING METHODS MARKET, BY REGION, 2020–2026 (USD MILLION)
8 RAPID MICROBIOLOGY TESTING MARKET, BY APPLICATION (Page No. - 112)
8.1 INTRODUCTION
TABLE 49 RAPID MICROBIOLOGY TESTING MARKET, BY APPLICATION, 2016–2019 (USD MILLION)
TABLE 50 RAPID MICROBIOLOGY TESTING MARKET, BY APPLICATION, 2020–2026 (USD MILLION)
8.2 CLINICAL DISEASE DIAGNOSIS
8.2.1 HIGH BURDEN OF INFECTIOUS DISEASES AND HAIS TO PROPEL MARKET GROWTH
TABLE 51 RAPID MICROBIOLOGY TESTING MARKET FOR CLINICAL DISEASE DIAGNOSIS, BY REGION, 2016–2019 (USD MILLION)
TABLE 52 RAPID MICROBIOLOGY TESTING MARKET FOR CLINICAL DISEASE DIAGNOSIS, BY REGION, 2020–2026 (USD MILLION)
8.3 FOOD & BEVERAGE TESTING
8.3.1 FOOD & BEVERAGE TESTING IS THE FASTEST-GROWING APPLICATION SEGMENT IN THE RAPID MICROBIOLOGY TESTING MARKET
TABLE 53 RAPID MICROBIOLOGY TESTING MARKET FOR FOOD & BEVERAGE TESTING, BY REGION, 2016–2019 (USD MILLION)
TABLE 54 RAPID MICROBIOLOGY TESTING MARKET FOR FOOD & BEVERAGE TESTING, BY REGION, 2020–2026 (USD MILLION)
8.4 PHARMACEUTICAL & BIOLOGICAL DRUG TESTING
8.4.1 IMPROVED REGULATORY SCENARIO FOR DRUG DEVELOPMENT TO SUPPORT MARKET GROWTH
TABLE 55 RAPID MICROBIOLOGY TESTING MARKET FOR PHARMACEUTICAL & BIOLOGICAL DRUG TESTING, BY REGION, 2016–2019 (USD MILLION)
TABLE 56 RAPID MICROBIOLOGY TESTING MARKET FOR PHARMACEUTICAL & BIOLOGICAL DRUG TESTING, BY REGION, 2020–2026 (USD MILLION)
8.5 ENVIRONMENTAL TESTING
8.5.1 GROWING FOCUS ON ENVIRONMENTAL MONITORING WILL BOOST THE GROWTH OF THIS SEGMENT
TABLE 57 RAPID MICROBIOLOGY TESTING MARKET FOR ENVIRONMENTAL TESTING, BY REGION, 2016–2019 (USD MILLION)
TABLE 58 RAPID MICROBIOLOGY TESTING MARKET FOR ENVIRONMENTAL TESTING, BY REGION, 2020–2026 (USD MILLION)
8.6 COSMETICS & PERSONAL CARE PRODUCTS TESTING
8.6.1 RAPID MICROBIOLOGY TESTING IS WIDELY USED IN THESE INDUSTRIES TO DETERMINE THE PRESENCE OF MICROBES IN THE MANUFACTURING PROCESS
TABLE 59 RAPID MICROBIOLOGY TESTING MARKET FOR COSMETICS & PERSONAL CARE PRODUCTS TESTING, BY REGION, 2016–2019 (USD MILLION)
TABLE 60 RAPID MICROBIOLOGY TESTING MARKET FOR COSMETICS & PERSONAL CARE PRODUCTS TESTING, BY REGION, 2020–2026 (USD MILLION)
8.7 RESEARCH APPLICATIONS
8.7.1 INCREASING USE OF MICROBIOLOGY TESTING SERVICES BY ACADEMIC & RESEARCH INSTITUTES TO DRIVE MARKET GROWTH
TABLE 61 RAPID MICROBIOLOGY TESTING MARKET FOR RESEARCH APPLICATIONS, BY REGION, 2016–2019 (USD MILLION)
TABLE 62 RAPID MICROBIOLOGY TESTING MARKET FOR RESEARCH APPLICATIONS, BY REGION, 2020–2026 (USD MILLION)
8.8 OTHER APPLICATIONS
TABLE 63 RAPID MICROBIOLOGY TESTING MARKET FOR OTHER APPLICATIONS, BY REGION, 2016–2019 (USD MILLION)
TABLE 64 RAPID MICROBIOLOGY TESTING MARKET FOR OTHER APPLICATIONS, BY REGION, 2020–2026 (USD MILLION)
9 RAPID MICROBIOLOGY TESTING MARKET, BY REGION (Page No. - 126)
9.1 INTRODUCTION
TABLE 65 RAPID MICROBIOLOGY TESTING MARKET, BY REGION, 2016–2019 (USD MILLION)
TABLE 66 RAPID MICROBIOLOGY TESTING MARKET, BY REGION, 2020–2026 (USD MILLION)
9.2 NORTH AMERICA
FIGURE 24 NORTH AMERICA: RAPID MICROBIOLOGY TESTING MARKET SNAPSHOT
TABLE 67 NORTH AMERICA: RAPID MICROBIOLOGY TESTING MARKET, BY COUNTRY, 2016–2019 (USD MILLION)
TABLE 68 NORTH AMERICA: RAPID MICROBIOLOGY TESTING MARKET, BY COUNTRY, 2020–2026 (USD MILLION)
TABLE 69 NORTH AMERICA: RAPID MICROBIOLOGY TESTING MARKET, BY PRODUCT, 2016–2019 (USD MILLION)
TABLE 70 NORTH AMERICA: RAPID MICROBIOLOGY TESTING MARKET, BY PRODUCT, 2020–2026 (USD MILLION)
TABLE 71 NORTH AMERICA: RAPID MICROBIOLOGY TESTING MARKET, BY METHOD, 2016–2019 (USD MILLION)
TABLE 72 NORTH AMERICA: RAPID MICROBIOLOGY TESTING MARKET, BY METHOD, 2020–2026 (USD MILLION)
TABLE 73 NORTH AMERICA: RAPID MICROBIOLOGY TESTING MARKET, BY APPLICATION, 2016–2019 (USD MILLION)
TABLE 74 NORTH AMERICA: RAPID MICROBIOLOGY TESTING MARKET, BY APPLICATION, 2020–2026 (USD MILLION)
9.2.1 US
9.2.1.1 Adoption of technologically advanced products in the US to favor market growth
TABLE 75 US: RAPID MICROBIOLOGY TESTING MARKET, BY PRODUCT, 2016–2019 (USD MILLION)
TABLE 76 US: RAPID MICROBIOLOGY TESTING MARKET, BY PRODUCT, 2020–2026 (USD MILLION)
TABLE 77 US: RAPID MICROBIOLOGY TESTING INSTRUMENTS MARKET, BY TYPE, 2016–2019 (USD MILLION)
TABLE 78 US: RAPID MICROBIOLOGY TESTING INSTRUMENTS MARKET, BY TYPE, 2020–2026 (USD MILLION)
TABLE 79 US: RAPID MICROBIOLOGY TESTING MARKET, BY METHOD, 2016–2019 (USD MILLION)
TABLE 80 US: RAPID MICROBIOLOGY TESTING MARKET, BY METHOD, 2020–2026 (USD MILLION)
TABLE 81 US: RAPID MICROBIOLOGY TESTING MARKET, BY APPLICATION, 2016–2019 (USD MILLION)
TABLE 82 US: RAPID MICROBIOLOGY TESTING MARKET, BY APPLICATION, 2020–2026 (USD MILLION)
9.2.2 CANADA
9.2.2.1 Favorable environment for R&D and rising incidence of infectious diseases to drive the rapid microbiology testing market in Canada
TABLE 83 CANADA: RAPID MICROBIOLOGY TESTING MARKET, BY PRODUCT, 2016–2019 (USD MILLION)
TABLE 84 CANADA: RAPID MICROBIOLOGY TESTING MARKET, BY PRODUCT, 2020–2026 (USD MILLION)
TABLE 85 CANADA: RAPID MICROBIOLOGY TESTING INSTRUMENTS MARKET, BY TYPE, 2016–2019 (USD MILLION)
TABLE 86 CANADA: RAPID MICROBIOLOGY TESTING INSTRUMENTS MARKET, BY TYPE, 2020–2026 (USD MILLION)
TABLE 87 CANADA: RAPID MICROBIOLOGY TESTING MARKET, BY METHOD, 2016–2019 (USD MILLION)
TABLE 88 CANADA: RAPID MICROBIOLOGY TESTING MARKET, BY METHOD, 2020–2026 (USD MILLION)
TABLE 89 CANADA: RAPID MICROBIOLOGY TESTING MARKET, BY APPLICATION, 2016–2019 (USD MILLION)
TABLE 90 CANADA: RAPID MICROBIOLOGY TESTING MARKET, BY APPLICATION, 2020–2026 (USD MILLION)
9.3 EUROPE
TABLE 91 EUROPE: RAPID MICROBIOLOGY TESTING MARKET, BY COUNTRY, 2016–2019 (USD MILLION)
TABLE 92 EUROPE: RAPID MICROBIOLOGY TESTING MARKET, BY COUNTRY, 2020–2026 (USD MILLION)
TABLE 93 EUROPE: RAPID MICROBIOLOGY TESTING MARKET, BY PRODUCT, 2016–2019 (USD MILLION)
TABLE 94 EUROPE: RAPID MICROBIOLOGY TESTING MARKET, BY PRODUCT, 2020–2026 (USD MILLION)
TABLE 95 EUROPE: RAPID MICROBIOLOGY TESTING MARKET, BY METHOD, 2016–2019 (USD MILLION)
TABLE 96 EUROPE: RAPID MICROBIOLOGY TESTING MARKET, BY METHOD, 2020–2026 (USD MILLION)
TABLE 97 EUROPE: RAPID MICROBIOLOGY TESTING MARKET, BY APPLICATION, 2016–2019 (USD MILLION)
TABLE 98 EUROPE: RAPID MICROBIOLOGY TESTING MARKET, BY APPLICATION, 2020–2026 (USD MILLION)
9.3.1 GERMANY
9.3.1.1 Germany is the largest & fastest-growing market for rapid microbiology testing in Europe
TABLE 99 GERMANY: RAPID MICROBIOLOGY TESTING MARKET, BY PRODUCT, 2016–2019 (USD MILLION)
TABLE 100 GERMANY: RAPID MICROBIOLOGY TESTING MARKET, BY PRODUCT, 2020–2026 (USD MILLION)
TABLE 101 GERMANY: RAPID MICROBIOLOGY TESTING INSTRUMENTS MARKET, BY TYPE, 2016–2019 (USD MILLION)
TABLE 102 GERMANY: RAPID MICROBIOLOGY TESTING INSTRUMENTS MARKET, BY TYPE, 2020–2026 (USD MILLION)
TABLE 103 GERMANY: RAPID MICROBIOLOGY TESTING MARKET, BY METHOD, 2016–2019 (USD MILLION)
TABLE 104 GERMANY: RAPID MICROBIOLOGY TESTING MARKET, BY METHOD, 2020–2026 (USD MILLION)
TABLE 105 GERMANY: RAPID MICROBIOLOGY TESTING MARKET, BY APPLICATION, 2016–2019 (USD MILLION)
TABLE 106 GERMANY: RAPID MICROBIOLOGY TESTING MARKET, BY APPLICATION, 2020–2026 (USD MILLION)
9.3.2 FRANCE
9.3.2.1 Rising R&D expenditure to drive market growth
TABLE 107 FRANCE: RAPID MICROBIOLOGY TESTING MARKET, BY PRODUCT, 2016–2019 (USD MILLION)
TABLE 108 FRANCE: RAPID MICROBIOLOGY TESTING MARKET, BY PRODUCT, 2020–2026 (USD MILLION)
TABLE 109 FRANCE: RAPID MICROBIOLOGY TESTING INSTRUMENTS MARKET, BY TYPE, 2016–2019 (USD MILLION)
TABLE 110 FRANCE: RAPID MICROBIOLOGY TESTING INSTRUMENTS MARKET, BY TYPE, 2020–2026 (USD MILLION)
TABLE 111 FRANCE: RAPID MICROBIOLOGY TESTING MARKET, BY METHOD, 2016–2019 (USD MILLION)
TABLE 112 FRANCE: RAPID MICROBIOLOGY TESTING MARKET, BY METHOD, 2020–2026 (USD MILLION)
TABLE 113 FRANCE: RAPID MICROBIOLOGY TESTING MARKET, BY APPLICATION, 2016–2019 (USD MILLION)
TABLE 114 FRANCE: RAPID MICROBIOLOGY TESTING MARKET, BY APPLICATION, 2020–2026 (USD MILLION)
9.3.3 UK
9.3.3.1 Increasing investments and funding by the government to drive the market growth in the UK
TABLE 115 UK: RAPID MICROBIOLOGY TESTING MARKET, BY PRODUCT, 2016–2019 (USD MILLION)
TABLE 116 UK: RAPID MICROBIOLOGY TESTING MARKET, BY PRODUCT, 2020–2026 (USD MILLION)
TABLE 117 UK: RAPID MICROBIOLOGY TESTING INSTRUMENTS MARKET, BY TYPE, 2016–2019 (USD MILLION)
TABLE 118 UK: RAPID MICROBIOLOGY TESTING INSTRUMENTS MARKET, BY TYPE, 2020–2026 (USD MILLION)
TABLE 119 UK: RAPID MICROBIOLOGY TESTING MARKET, BY METHOD, 2016–2019 (USD MILLION)
TABLE 120 UK: RAPID MICROBIOLOGY TESTING MARKET, BY METHOD, 2020–2026 (USD MILLION)
TABLE 121 UK: RAPID MICROBIOLOGY TESTING MARKET, BY APPLICATION, 2016–2019 (USD MILLION)
TABLE 122 UK: RAPID MICROBIOLOGY TESTING MARKET, BY APPLICATION, 2020–2026 (USD MILLION)
9.3.4 REST OF EUROPE
TABLE 123 ROE: RAPID MICROBIOLOGY TESTING MARKET, BY PRODUCT, 2016–2019 (USD MILLION)
TABLE 124 ROE: RAPID MICROBIOLOGY TESTING MARKET, BY PRODUCT, 2020–2026 (USD MILLION)
TABLE 125 ROE: RAPID MICROBIOLOGY TESTING INSTRUMENTS MARKET, BY TYPE, 2016–2019 (USD MILLION)
TABLE 126 ROE: RAPID MICROBIOLOGY TESTING INSTRUMENTS MARKET, BY TYPE, 2020–2026 (USD MILLION)
TABLE 127 ROE: RAPID MICROBIOLOGY TESTING MARKET, BY METHOD, 2016–2019 (USD MILLION)
TABLE 128 ROE: RAPID MICROBIOLOGY TESTING MARKET, BY METHOD, 2020–2026 (USD MILLION)
TABLE 129 ROE: RAPID MICROBIOLOGY TESTING MARKET, BY APPLICATION, 2016–2019 (USD MILLION)
TABLE 130 ROE: RAPID MICROBIOLOGY TESTING MARKET, BY APPLICATION, 2020–2026 (USD MILLION)
9.4 ASIA PACIFIC
FIGURE 25 ASIA PACIFIC: RAPID MICROBIOLOGY TESTING MARKET SNAPSHOT
TABLE 131 ASIA PACIFIC: RAPID MICROBIOLOGY TESTING MARKET, BY COUNTRY, 2016–2019 (USD MILLION)
TABLE 132 ASIA PACIFIC: RAPID MICROBIOLOGY TESTING MARKET, BY COUNTRY, 2020–2026 (USD MILLION)
TABLE 133 ASIA PACIFIC: RAPID MICROBIOLOGY TESTING MARKET, BY PRODUCT, 2016–2019 (USD MILLION)
TABLE 134 ASIA PACIFIC: RAPID MICROBIOLOGY TESTING MARKET, BY PRODUCT, 2020–2026 (USD MILLION)
TABLE 135 ASIA PACIFIC: RAPID MICROBIOLOGY TESTING MARKET, BY METHOD, 2016–2019 (USD MILLION)
TABLE 136 ASIA PACIFIC: RAPID MICROBIOLOGY TESTING MARKET, BY METHOD, 2020–2026 (USD MILLION)
TABLE 137 ASIA PACIFIC: RAPID MICROBIOLOGY TESTING MARKET, BY APPLICATION, 2016–2019 (USD MILLION)
TABLE 138 ASIA PACIFIC: RAPID MICROBIOLOGY TESTING MARKET, BY APPLICATION, 2020–2026 (USD MILLION)
9.4.1 CHINA
9.4.1.1 Increasing funding for R&D to drive market growth
TABLE 139 CHINA: KEY MACROINDICATORS
TABLE 140 CHINA: RAPID MICROBIOLOGY TESTING MARKET, BY PRODUCT, 2016–2019 (USD MILLION)
TABLE 141 CHINA: RAPID MICROBIOLOGY TESTING MARKET, BY PRODUCT, 2020–2026 (USD MILLION)
TABLE 142 CHINA: RAPID MICROBIOLOGY TESTING INSTRUMENTS MARKET, BY TYPE, 2016–2019 (USD MILLION)
TABLE 143 CHINA: RAPID MICROBIOLOGY TESTING INSTRUMENTS MARKET, BY TYPE, 2020–2026 (USD MILLION)
TABLE 144 CHINA: RAPID MICROBIOLOGY TESTING MARKET, BY METHOD, 2016–2019 (USD MILLION)
TABLE 145 CHINA: RAPID MICROBIOLOGY TESTING MARKET, BY METHOD, 2020–2026 (USD MILLION)
TABLE 146 CHINA: RAPID MICROBIOLOGY TESTING MARKET, BY APPLICATION, 2016–2019 (USD MILLION)
TABLE 147 CHINA: RAPID MICROBIOLOGY TESTING MARKET, BY APPLICATION, 2020–2026 (USD MILLION)
9.4.2 JAPAN
9.4.2.1 Rising geriatric population in Japan to support market growth
TABLE 148 JAPAN: KEY MACROINDICATORS
TABLE 149 JAPAN: RAPID MICROBIOLOGY TESTING MARKET, BY PRODUCT, 2016–2019 (USD MILLION)
TABLE 150 JAPAN: RAPID MICROBIOLOGY TESTING MARKET, BY PRODUCT, 2020–2026 (USD MILLION)
TABLE 151 JAPAN: RAPID MICROBIOLOGY TESTING INSTRUMENTS MARKET, BY TYPE, 2016–2019 (USD MILLION)
TABLE 152 JAPAN: RAPID MICROBIOLOGY TESTING INSTRUMENTS MARKET, BY TYPE, 2020–2026 (USD MILLION)
TABLE 153 JAPAN: RAPID MICROBIOLOGY TESTING MARKET, BY METHOD, 2016–2019 (USD MILLION)
TABLE 154 JAPAN: RAPID MICROBIOLOGY TESTING MARKET, BY METHOD, 2020–2026 (USD MILLION)
TABLE 155 JAPAN: RAPID MICROBIOLOGY TESTING MARKET, BY APPLICATION, 2016–2019 (USD MILLION)
TABLE 156 JAPAN: RAPID MICROBIOLOGY TESTING MARKET, BY APPLICATION, 2020–2026 (USD MILLION)
9.4.3 INDIA
9.4.3.1 High incidence of infectious diseases in the country to drive the adoption of rapid microbiology testing products
TABLE 157 INDIA: RAPID MICROBIOLOGY TESTING MARKET, BY PRODUCT, 2016–2019 (USD MILLION)
TABLE 158 INDIA: RAPID MICROBIOLOGY TESTING MARKET, BY PRODUCT, 2020–2026 (USD MILLION)
TABLE 159 INDIA: RAPID MICROBIOLOGY TESTING INSTRUMENTS MARKET, BY TYPE, 2016–2019 (USD MILLION)
TABLE 160 INDIA: RAPID MICROBIOLOGY TESTING INSTRUMENTS MARKET, BY TYPE, 2020–2026 (USD MILLION)
TABLE 161 INDIA: RAPID MICROBIOLOGY TESTING MARKET, BY METHOD, 2016–2019 (USD MILLION)
TABLE 162 INDIA: RAPID MICROBIOLOGY TESTING MARKET, BY METHOD, 2020–2026 (USD MILLION)
TABLE 163 INDIA: RAPID MICROBIOLOGY TESTING MARKET, BY APPLICATION, 2016–2019 (USD MILLION)
TABLE 164 INDIA: RAPID MICROBIOLOGY TESTING MARKET, BY APPLICATION, 2020–2026 (USD MILLION)
9.4.4 REST OF ASIA PACIFIC
TABLE 165 ROAPAC: RAPID MICROBIOLOGY TESTING MARKET, BY PRODUCT, 2016–2019 (USD MILLION)
TABLE 166 ROAPAC: RAPID MICROBIOLOGY TESTING MARKET, BY PRODUCT, 2020–2026 (USD MILLION)
TABLE 167 ROAPAC: RAPID MICROBIOLOGY TESTING INSTRUMENTS MARKET, BY TYPE, 2016–2019 (USD MILLION)
TABLE 168 ROAPAC: RAPID MICROBIOLOGY TESTING INSTRUMENTS MARKET, BY TYPE, 2020–2026 (USD MILLION)
TABLE 169 ROAPAC: RAPID MICROBIOLOGY TESTING MARKET, BY METHOD, 2016–2019 (USD MILLION)
TABLE 170 ROAPAC: RAPID MICROBIOLOGY TESTING MARKET, BY METHOD, 2020–2026 (USD MILLION)
TABLE 171 ROAPAC: RAPID MICROBIOLOGY TESTING MARKET, BY APPLICATION, 2016–2019 (USD MILLION)
TABLE 172 ROAPAC: RAPID MICROBIOLOGY TESTING MARKET, BY APPLICATION, 2020–2026 (USD MILLION)
9.5 LATIN AMERICA
9.5.1 INCREASING PER CAPITA HEALTHCARE EXPENDITURE TO SUPPORT MARKET GROWTH
TABLE 173 LATIN AMERICA: RAPID MICROBIOLOGY TESTING MARKET, BY PRODUCT, 2016–2019 (USD MILLION)
TABLE 174 LATIN AMERICA: RAPID MICROBIOLOGY TESTING MARKET, BY PRODUCT, 2020–2026 (USD MILLION)
TABLE 175 LATIN AMERICA: RAPID MICROBIOLOGY TESTING MARKET, BY METHOD, 2016–2019 (USD MILLION)
TABLE 176 LATIN AMERICA: RAPID MICROBIOLOGY TESTING MARKET, BY METHOD, 2020–2026 (USD MILLION)
TABLE 177 LATIN AMERICA: RAPID MICROBIOLOGY TESTING MARKET, BY APPLICATION, 2016–2019 (USD MILLION)
TABLE 178 LATIN AMERICA: RAPID MICROBIOLOGY TESTING MARKET, BY APPLICATION, 2020–2026 (USD MILLION)
9.6 MIDDLE EAST & AFRICA
9.6.1 GOVERNMENT INITIATIVES TO IMPROVE HEALTHCARE INFRASTRUCTURE TO PROPEL MARKET GROWTH
TABLE 179 MIDDLE EAST & AFRICA: RAPID MICROBIOLOGY TESTING MARKET, BY PRODUCT, 2016–2019 (USD MILLION)
TABLE 180 MIDDLE EAST & AFRICA: RAPID MICROBIOLOGY TESTING MARKET, BY PRODUCT, 2020–2026 (USD MILLION)
TABLE 181 MIDDLE EAST & AFRICA: RAPID MICROBIOLOGY TESTING MARKET, BY METHOD, 2016–2019 (USD MILLION)
TABLE 182 MIDDLE EAST & AFRICA: RAPID MICROBIOLOGY TESTING MARKET, BY METHOD, 2020–2026 (USD MILLION)
TABLE 183 MIDDLE EAST & AFRICA: RAPID MICROBIOLOGY TESTING MARKET, BY APPLICATION, 2016–2019 (USD MILLION)
TABLE 184 MIDDLE EAST & AFRICA: RAPID MICROBIOLOGY TESTING MARKET, BY APPLICATION, 2020–2026 (USD MILLION)
10 COMPETITIVE LANDSCAPE (Page No. - 194)
10.1 OVERVIEW
10.2 KEY PLAYER STRATEGIES/RIGHT TO WIN
10.2.1 OVERVIEW OF STRATEGIES DEPLOYED BY PLAYERS IN THE RAPID MICROBIOLOGY TESTING MARKET
TABLE 185 OVERVIEW OF STRATEGIES DEPLOYED BY KEY RAPID MICROBIOLOGY TESTING MANUFACTURING COMPANIES
10.3 REVENUE SHARE ANALYSIS OF THE TOP MARKET PLAYERS
FIGURE 26 REVENUE SHARE ANALYSIS OF THE TOP PLAYERS IN THE RAPID MICROBIOLOGY TESTING MARKET
10.4 MARKET SHARE ANALYSIS
FIGURE 27 RAPID MICROBIOLOGY TESTING MARKET SHARE, BY KEY PLAYER (2020)
TABLE 186 RAPID MICROBIOLOGY TESTING MARKET: DEGREE OF COMPETITION
10.5 COMPANY EVALUATION QUADRANT
10.5.1 LIST OF EVALUATED VENDORS
10.5.2 STARS
10.5.3 EMERGING LEADERS
10.5.4 PERVASIVE PLAYERS
10.5.5 PARTICIPANTS
FIGURE 28 RAPID MICROBIOLOGY TESTING MARKET: COMPETITIVE LEADERSHIP MAPPING, 2020
10.6 COMPETITIVE LEADERSHIP MAPPING FOR STARTUPS/SMES (2020)
10.6.1 PROGRESSIVE COMPANIES
10.6.2 STARTING BLOCKS
10.6.3 RESPONSIVE COMPANIES
10.6.4 DYNAMIC COMPANIES
FIGURE 29 RAPID MICROBIOLOGY TESTING MARKET: COMPETITIVE LEADERSHIP MAPPING FOR STARTUPS/SMES, 2020
10.7 COMPETITIVE BENCHMARKING
FIGURE 30 PRODUCT AND GEOGRAPHICAL FOOTPRINT ANALYSIS OF THE TOP PLAYERS IN THE RAPID MICROBIOLOGY TESTING MARKET
TABLE 187 COMPANY PRODUCT FOOTPRINT
TABLE 188 COMPANY GEOGRAPHICAL FOOTPRINT
10.8 COMPETITIVE SCENARIO
10.8.1 PRODUCT LAUNCHES & REGULATORY APPROVALS
TABLE 189 KEY PRODUCT LAUNCHES & REGULATORY APPROVALS
10.8.2 DEALS
TABLE 190 KEY DEALS
11 COMPANY PROFILES (Page No. - 206)
11.1 KEY PLAYERS
(Business Overview, Products Offered, Recent Developments, and MnM View (Key strengths/Right to Win, Strategic Choices Made, and Weaknesses and Competitive Threats))*
11.1.1 BIOMÉRIEUX SA
TABLE 191 BIOMÉRIEUX: BUSINESS OVERVIEW
FIGURE 31 BIOMÉRIEUX SA: COMPANY SNAPSHOT (2020)
11.1.2 DANAHER CORPORATION
TABLE 192 DANAHER CORPORATION: BUSINESS OVERVIEW
FIGURE 32 DANAHER CORPORATION: COMPANY SNAPSHOT (2020)
11.1.3 BECTON, DICKINSON AND COMPANY
TABLE 193 BECTON, DICKINSON AND COMPANY: BUSINESS OVERVIEW
FIGURE 33 BECTON, DICKINSON AND COMPANY: COMPANY SNAPSHOT (2020)
11.1.4 ABBOTT LABORATORIES
TABLE 194 ABBOTT LABORATORIES: BUSINESS OVERVIEW
FIGURE 34 ABBOTT LABORATORIES: COMPANY SNAPSHOT (2020)
11.1.5 THERMO FISHER SCIENTIFIC INC.
TABLE 195 THERMO FISHER SCIENTIFIC INC.: BUSINESS OVERVIEW
FIGURE 35 THERMO FISHER SCIENTIFIC INC.: COMPANY SNAPSHOT (2020)
11.1.6 MERCK KGAA
TABLE 196 MERCK KGAA: BUSINESS OVERVIEW
FIGURE 36 MERCK KGAA: COMPANY SNAPSHOT (2020)
11.1.7 SARTORIUS AG
TABLE 197 SARTORIUS AG: BUSINESS OVERVIEW
FIGURE 37 SARTORIUS AG: COMPANY SNAPSHOT (2020)
11.1.8 BRUKER CORPORATION
TABLE 198 BRUKER CORPORATION: BUSINESS OVERVIEW
FIGURE 38 BRUKER CORPORATION: COMPANY SNAPSHOT (2020)
11.1.9 QUIDEL CORPORATION
TABLE 199 QUIDEL CORPORATION: BUSINESS OVERVIEW
FIGURE 39 QUIDEL CORPORATION: COMPANY SNAPSHOT (2020)
11.1.10 CHARLES RIVER LABORATORIES INTERNATIONAL, INC.
TABLE 200 CHARLES RIVER LABORATORIES INTERNATIONAL, INC.: BUSINESS OVERVIEW
FIGURE 40 CHARLES RIVER LABORATORIES INTERNATIONAL, INC.: COMPANY SNAPSHOT (2020)
11.1.11 NEOGEN CORPORATION
TABLE 201 NEOGEN CORPORATION: BUSINESS OVERVIEW
FIGURE 41 NEOGEN CORPORATION: COMPANY SNAPSHOT (2020)
11.2 OTHER PLAYERS
11.2.1 DON WHITLEY SCIENTIFIC
TABLE 202 DON WHITLEY SCIENTIFIC: BUSINESS OVERVIEW
11.2.2 RAPID MICRO BIOSYSTEMS
TABLE 203 RAPID MICRO BIOSYSTEMS: BUSINESS OVERVIEW
11.2.3 VIVIONE BIOSCIENCES, LLC
TABLE 204 VIVIONE BIOSCIENCES, LLC: BUSINESS OVERVIEW
11.2.4 GRADIENTECH
TABLE 205 GRADIENTECH: BUSINESS OVERVIEW
11.2.5 RQMICRO AG
TABLE 206 RQMICRO AG: BUSINESS OVERVIEW
11.2.6 BACTEST LTD.
TABLE 207 BACTEST LTD.: BUSINESS OVERVIEW
11.2.7 COLIFAST
TABLE 208 COLIFAST: BUSINESS OVERVIEW
11.2.8 SEROSEP LTD.
TABLE 209 SEROSEP LTD.: BUSINESS OVERVIEW
11.2.9 BIOSENSIA LTD.
TABLE 210 BIOSENSIA LTD.: BUSINESS OVERVIEW
11.2.10 SOLUS SCIENTIFIC SOLUTIONS LTD.
TABLE 211 SOLUS SCIENTIFIC SOLUTIONS LTD.: BUSINESS OVERVIEW
11.2.11 LUBIOSCIENCE GMBH
TABLE 212 LUBIOSCIENCE GMBH: BUSINESS OVERVIEW
11.2.12 EUROCLONE SPA
TABLE 213 EUROCLONE SPA: BUSINESS OVERVIEW
11.2.13 CORDX
TABLE 214 CORDX: BUSINESS OVERVIEW
11.2.14 R-BIOPHARM AG
TABLE 215 R-BIOPHARM AG: BUSINESS OVERVIEW
*Details on Business Overview, Products Offered, Recent Developments, and MnM View (Key strengths/Right to Win, Strategic Choices Made, and Weaknesses and Competitive Threats) might not be captured in case of unlisted companies.
12 APPENDIX (Page No. - 269)
12.1 INSIGHTS FROM INDUSTRY EXPERTS
12.2 DISCUSSION GUIDE
12.3 KNOWLEDGE STORE: MARKETSANDMARKETS’ SUBSCRIPTION PORTAL
12.4 AVAILABLE CUSTOMIZATIONS
12.5 RELATED REPORTS
12.6 AUTHOR DETAILS
This study involved four major activities in estimating the current size of the rapid microbiology testing market. Exhaustive secondary research was carried out to collect information on the market, its peer markets, and its parent market. The next step was to validate these findings, assumptions, and sizing with industry experts across the value chain through primary research. Both top-down and bottom-up approaches were employed to estimate the complete market size. After that, market breakdown and data triangulation procedures were used to estimate segments and subsegments' market size.
Secondary Research
In the secondary research process, various secondary sources such as annual reports, press releases & investor presentations of companies, white papers, certified publications, articles by recognized authors, gold-standard & silver-standard websites, regulatory bodies, and databases (such as D&B Hoovers, Bloomberg Business, and Factiva) were referred to identify and collect information for this study.
Primary Research
In the primary research process, various sources from both the supply and demand sides were interviewed to obtain qualitative and quantitative information for this report. Primary sources were mainly industry experts from the core and related industries and preferred suppliers, manufacturers, distributors, service providers, technology developers, researchers, and organizations related to all segments of this industry’s value chain. In-depth interviews were conducted with various primary respondents, including key industry participants, subject-matter experts, C-level executives of key market players, and industry consultants, to obtain and verify the critical qualitative and quantitative information as well as assess future prospects.
The following is a breakdown of the primary respondents:
To know about the assumptions considered for the study, download the pdf brochure
Market Size Estimation
Both top-down and bottom-up approaches were used to estimate and validate the rapid microbiology testing market's total size. These methods were also used extensively to estimate the size of various subsegments in the market. The research methodology used to estimate the market size includes the following:
- The key players in the industry have been identified through extensive secondary research
- The revenues generated by leading players operating in the electroceuticals market have been determined through primary and secondary research
- All percentage shares, splits, and breakdowns have been determined using secondary sources and verified through primary sources
Global Rapid Microbiology Testing Market Size: Top-Down Approach
To know about the assumptions considered for the study, Request for Free Sample Report
Data Triangulation
After arriving at the overall market size applying the process mentioned above, the total market was split into several segments and subsegments. To complete the overall market engineering process and arrive at the exact statistics for all segments and subsegments, data triangulation and market breakdown procedures were employed, wherever applicable. The data was triangulated by studying various factors and trends from both the demand and supply sides.
Report Objectives
- To define, describe, segment, and forecast the rapid microbiology testing market by product, method, application and region.
- To provide detailed information regarding the major factors influencing the market growth (drivers, restraints, opportunities, and challenges)
- To analyze micromarkets1 with respect to individual growth trends, prospects, and contributions to the overall market
- To analyze market opportunities for stakeholders and provide details of the competitive landscape for key players.
- To forecast the size of the market segments with respect to five regions, namely, North America, Europe, the Asia Pacific, Latin America, and the Middle East & Africa
- To profile the key players and comprehensively analyze their product portfolios, market positions, and core competencies2.
- To track and analyze company developments such as product launches, agreements, expansions, and acquisitions in the rapid microbiology testing market.
- To benchmark players within the market using the proprietary “Competitive Leadership Mapping” framework, which analyzes market players on various parameters within the broad categories of business and product strategy.
Available Customizations
With the given market data, MarketsandMarkets offers customizations as per the company’s specific needs. The following customization options are available for this report:
Country Information
Rapid Microbiology Testing market size and growth rate estimates for countries in the Rest of Europe, the Rest of Asia Pacific, Latin America, and Middle East & Africa
Company profiles
Additional five company profiles of players operating in the electroceuticals market
- Triangulate with your Own Data
- Get Data as per your Format and Definition
- Gain a Deeper Dive on a Specific Application, Geography, Customer or Competitor
- Any level of Personalization
- What are the Known and Unknown Adjacencies Impacting the Rapid Microbiology Testing Market
- What will your New Revenue Sources be?
- Who will be your Top Customer; what will make them switch?
- Defend your Market Share or Win Competitors
- Get a Scorecard for Target Partners
Growth opportunities and latent adjacency in Rapid Microbiology Testing Market